The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients

OBJECTIVE: The objective of this study is to compute the potential benefit of Pramipexole ER on total levodopa equivalent dose (LED) and Unified Parkinson Disease Rating Score (UPDRS-III) compared to mono- or combined therapy of pramipexole IR and/or carbidopa/levodopa. METHODS: This is a retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Faddoul, Lama, Chahine, Bahia, Haydar, Sahar, Abourida, Sahar, Hallit, Souheil, Raad, Etwal Bou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322989/
https://www.ncbi.nlm.nih.gov/pubmed/30637025
http://dx.doi.org/10.18549/PharmPract.2018.04.1220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322989/
https://www.ncbi.nlm.nih.gov/pubmed/30637025
http://dx.doi.org/10.18549/PharmPract.2018.04.1220

Ejemplares similares